- Home
- PAVM vs GSIW Comparison
PAVM vs GSIW Comparison
Compare PAVM & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAVM | GSIW |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | Hong Kong |
| Employees | 41 | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.1M | 42.6M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | PAVM | GSIW |
|---|---|---|
| Price | $5.79 | $27.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $65.00 | N/A |
| AVG Volume (30 Days) | ★ 19.6K | 7.2K |
| Earning Date | 05-15-2026 | 08-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $603.94 | N/A |
| Revenue Next Year | $33.16 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $0.05 |
| 52 Week High | $28.44 | $38.55 |
Technical Indicators
Market Signals| Indicator | PAVM | GSIW |
|---|---|---|
| Relative Strength Index (RSI) | 52.95 | 47.38 |
| Support Level | $0.30 | $26.17 |
| Resistance Level | $6.53 | $33.00 |
| Average True Range (ATR) | 0.47 | 1.71 |
| MACD | 0.11 | -0.10 |
| Stochastic Oscillator | 60.00 | 23.78 |
Price Performance
Historical ComparisonAbout PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.